Good participatory practice: Guidelines for biomedical HIV prevention trials (2011)
The good participatory practice (GPP) guidelines provide trial funders, sponsors, and implementers with systematic guidance on how to effectively engage with stakeholders in the design and conduct of biomedical HIV prevention trials. In the GPP guidelines, “design and conduct of biomedical HIV prevention trials” refers to activities required for the development, planning, implementation, and conclusion of a trial, including dissemination of trial results.
Related feature storiesWorld leaders unite towards ending the AIDS epidemic among adolescents
29 September 2014Leaving no one behind in the post-2015 development agenda: young marginalized people claim their space
26 September 2014Action on sexual and reproductive health and rights critical say leaders
24 September 2014